Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients

<div>Cumulative incidence of patient survival. (a) Patient survival compared between different antiviral agents before propensity score matching. (b) Patient survival compared different antiviral agents after propensity score matching.</div>

Advanced Gut & Microbiome Research

fig2

Figure 2

Figure 2: Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients 